Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6K5J42 Issuer Name ENDEAVOUR MINING PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or...
-
CONVOCATION A L’ASSEMBLEE GENERALE DES ACTIONNAIRES Le Conseil d’administration invite les actionnaires à l’assemblée générale des actionnaires (« l’Assemblée Générale ») qui se tiendra le jeudi 30...
-
CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS The Board of Directors invites the shareholders to the general meeting of the shareholders (the “General Meeting”) which will be held on...
-
93% of candidates experience interview anxiety. New data reveals the questions that cause the most panic and why a growing number are turning to AI.
-
Graduate unemployment is at its highest since 2020. The Class of 2025's response? They're refusing to interview without AI — and they're not apologizing.
-
Dubai, UAE, March 26, 2026 (GLOBE NEWSWIRE) -- The Ethereum based crypto Pepeto just announced a major DeFi tools update across its exchange, bridge, and AI security layer, and the presale crossed...
-
Dubai, UAE, March 26, 2026 (GLOBE NEWSWIRE) -- The Pepeto project just delivered a fresh security upgrade across its exchange while the XRP price prediction improves on real catalysts. In the same...
-
Châtillon, France, le 26 mars 2026 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2025 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 -...
-
Châtillon, France, March 26, 2026 DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 –...
-
Châtillon, France, 26 mars 2026 DBV Technologies publie ses résultats financiers annuels 2025 et fait le point sur ses activités Poursuite des avancées du programme de développement clinique du...